{"id":"https://openalex.org/W2589615641","doi":"https://doi.org/10.1182/blood.v116.21.472.472","title":"Next Generation Sequencing Identifies Novel Oncogene Alterations In CRLF2-rearranged Precursor B-Cell Acute Lymphoblastic Leukemia","display_name":"Next Generation Sequencing Identifies Novel Oncogene Alterations In CRLF2-rearranged Precursor B-Cell Acute Lymphoblastic Leukemia","publication_year":2010,"publication_date":"2010-11-19","ids":{"openalex":"https://openalex.org/W2589615641","doi":"https://doi.org/10.1182/blood.v116.21.472.472","mag":"2589615641"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v116.21.472.472","doi":"https://doi.org/10.1182/blood.v116.21.472.472","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.472.472","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069614210","display_name":"Akinori Yoda","orcid":"https://orcid.org/0000-0002-7806-1909","observed_orcids":["https://orcid.org/0000-0002-7806-1909"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Akinori Yoda","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010014668","display_name":"Terry M. Haley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Terry Haley","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048714300","display_name":"Oliver Weigert","orcid":"https://orcid.org/0000-0002-0987-7373","observed_orcids":["https://orcid.org/0000-0002-0987-7373"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oliver B. Weigert","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005876566","display_name":"Jeffery Lorne Kutok","orcid":"https://orcid.org/0009-0009-9931-3106","observed_orcids":["https://orcid.org/0009-0009-9931-3106"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffery Kutok","raw_affiliation_strings":["Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA,","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015108232","display_name":"Adalis Maisonet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Adalis Maisonet","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042045000","display_name":"Maura Salois","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Maura Salois","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101585265","display_name":"Edward Fox","orcid":"https://orcid.org/0000-0002-3740-651X","observed_orcids":["https://orcid.org/0000-0002-3740-651X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Edward Fox","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026688095","display_name":"David M. Weinstock","orcid":"https://orcid.org/0000-0002-8724-3907","observed_orcids":["https://orcid.org/0000-0002-8724-3907"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M Weinstock","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5010014668","https://openalex.org/A5015108232","https://openalex.org/A5042045000","https://openalex.org/A5069614210","https://openalex.org/A5101585265"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.3187,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.71631893,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"116","issue":"21","first_page":"472","last_page":"472"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crlf2-rearrangement","display_name":"CRLF2 rearrangement","score":0.9229999780654907},{"id":"https://openalex.org/keywords/b-cell-precursor-acute-lymphoblastic-leukemia","display_name":"B-cell precursor acute lymphoblastic leukemia","score":0.9290000200271606},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.8149999976158142},{"id":"https://openalex.org/keywords/jak2-mutation","display_name":"JAK2 mutation","score":0.7850000262260437},{"id":"https://openalex.org/keywords/tslpr","display_name":"TSLPR","score":0.593999981880188},{"id":"https://openalex.org/keywords/leukemogenesis","display_name":"leukemogenesis","score":0.6449999809265137},{"id":"https://openalex.org/keywords/rna-editing","display_name":"RNA editing","score":0.5149999856948853},{"id":"https://openalex.org/keywords/transcriptome-sequencing","display_name":"transcriptome sequencing","score":0.6010000109672546},{"id":"https://openalex.org/keywords/somatic-copy-number-alterations","display_name":"somatic copy number alterations","score":0.5019999742507935}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6457028388977051},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.5937197208404541},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.580798864364624},{"id":"https://openalex.org/C10590036","wikidata":"https://www.wikidata.org/wiki/Q417664","display_name":"Exome","level":5,"score":0.49636536836624146},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4398009181022644},{"id":"https://openalex.org/C51679486","wikidata":"https://www.wikidata.org/wiki/Q380546","display_name":"DNA sequencing","level":3,"score":0.42248648405075073},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.4006651043891907},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.39904412627220154},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3663240671157837},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3525852859020233},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.16910001635551453}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v116.21.472.472","doi":"https://doi.org/10.1182/blood.v116.21.472.472","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.472.472","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8999999761581421}],"sustainable_development_goals_aurora":[{"display_name":"No poverty","id":"https://metadata.un.org/sdg/1","score":0.6499999761581421}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2036999612","https://openalex.org/W2539509073","https://openalex.org/W7221107275","https://openalex.org/W2596667846","https://openalex.org/W2979572115","https://openalex.org/W2012114257","https://openalex.org/W4416626176","https://openalex.org/W4294916418","https://openalex.org/W2553781664","https://openalex.org/W2752000937"],"abstract_inverted_index":{"Abstract":[0,1],"472":[2],"We":[3],"and":[4,31,48,76,112,165,199,214,229,258,282,289,308,344,404,470,480],"others":[5],"recently":[6],"identified":[7,250,263,286,413,442],"locus":[8],"rearrangements":[9],"involving":[10],"the":[11,115,118,180,189,208,251,255,259,268,296,300,309,349,361,367,373,378,388,412,444,455,474],"type":[12],"I":[13],"cytokine":[14],"receptor":[15,24],"subunit":[16],"CRLF2":[17,39,43,81,105,121,148,320],"(also":[18],"known":[19,395],"as":[20,325],"thymic":[21],"stromal":[22],"lymphopoietin":[23],"(TSLPR))":[25],"in":[26,90,264,295,319,360,366,377,399,421,425,430,454,478],"5\u20137%":[27],"of":[28,74,85,120,183,223,246,280,351,411,432,448,464,473,489],"all":[29],"adult":[30],"pediatric":[32],"B-cell":[33],"precursor":[34],"acute":[35],"lymphoblastic":[36],"leukemia":[37],"(B-ALL).":[38],"rearrangement":[40],"places":[41],"full-length":[42],"under":[44],"alternate":[45],"transcriptional":[46],"control,":[47],"can":[49],"either":[50],"result":[51],"from":[52,58,155,166,179,191,267,331,372,381,387,443],"an":[53],"intrachromosomal":[54],"CRLF2-P2RY8":[55],"deletion":[56],"or":[57],"a":[59,71,104,220,244,327,332,422,461],"CRLF2-IGH":[60],"translocation.":[61],"Prognosis":[62],"for":[63],"CRLF2-rearranged":[64,86,142,479],"B-ALL":[65,79,87,143,163,482],"is":[66,123,483],"particularly":[67],"poor,":[68],"suggesting":[69],"that":[70,95,108,131,275,450],"sizable":[72],"fraction":[73],"relapsed":[75],"ultimately":[77],"fatal":[78],"harbor":[80,88],"rearrangements.":[82],"Approximately":[83],"50%":[84],"mutations":[89,294,358,414,440],"JAK2":[91,98,329,338],"(and":[92],"rarely":[93],"JAK1)":[94],"cluster":[96],"around":[97],"Arg683.":[99],"A":[100],"separate":[101],"15%":[102],"have":[103,415],"F232C":[106,149,321],"mutation":[107,253,260,318,330,420],"promotes":[109],"constitutive":[110],"homodimerization":[111],"signaling.":[113],"In":[114,435],"remaining":[116,310],"cases,":[117],"driver":[119],"signaling":[122],"not":[124,262,364,452],"known.":[125],"To":[126,407],"identify":[127,201],"additional":[128],"genetic":[129],"alterations":[130,376,392,477],"contribute":[132],"to":[133,336,396,491],"CRLF2-mediated":[134],"leukemogenesis,":[135],"we":[136],"performed":[137,175],"next-generation":[138],"sequencing":[139,172,279],"on":[140,176,196],"3":[141,247],"specimens,":[144],"including":[145],"one":[146],"with":[147,159,219],"(#536).":[150],"Exome":[151],"libraries":[152],"were":[153,239,306,313,385,441,451],"assembled":[154],"bone":[156,169],"marrow":[157,182,284,446,457],"specimens":[158,285],"greater":[160,224],"than":[161,225],"90%":[162],"involvement":[164],"paired":[167],"remission":[168,269,368],"marrows.":[170],"Transcriptome":[171],"was":[173,261,323,326,428],"also":[174],"cDNA":[177],"isolated":[178],"involved":[181,256,283,379,389,398,424,445,456],"patient":[184],"#536":[185,449],"to:":[186],"1)":[187],"confirm":[188],"findings":[190],"exome":[192,278,345,380],"sequencing,":[193],"2)":[194],"focus":[195],"transcribed":[197],"genes":[198,394],"3)":[200],"possible":[202],"RNA":[203,465],"editing":[204],"events.":[205],"Sequencing":[206],"utilized":[207],"SOLiD":[209],"(Sequencing":[210],"by":[211],"Oligonucleotide":[212],"Ligation":[213],"Detection;":[215],"Applied":[216],"BioSystems)":[217],"platform,":[218],"target":[221],"recovery":[222],"40":[226],"million":[227,231],"(transcriptome)":[228],"25":[230],"(exome)":[232],"uniquely":[233],"mapping":[234],"reads":[235,249,266,273],"per":[236],"sample.":[237],"Mutations":[238],"considered":[240],"high":[241,462],"confidence":[242],"if":[243],"minimum":[245],"individual":[248],"same":[252],"within":[254],"specimen":[257,270],"any":[265],"(minimum":[271],"10":[272],"at":[274],"base-pair).":[276],"Paired":[277],"germline":[281],"129,":[287],"297":[288],"630":[290],"high-confidence,":[291],"non-synonymous,":[292],"somatic":[293,375],"three":[297,433],"samples.":[298],"Of":[299],"total":[301],"1056":[302],"mutations,":[303],"1023":[304],"(96.9%)":[305],"missense":[307],"33":[311],"(3.1%)":[312],"nonsense":[314],"mutations.":[315],"The":[316],"expected":[317],"(#536)":[322],"recovered,":[324],"novel":[328,475],"sample":[333],"previously":[334,416],"thought":[335],"be":[337,397],"wild-type":[339],"(#002).":[340],"Comparison":[341],"between":[342],"transcriptome":[343,447],"sequence":[346,439,468,476],"markedly":[347],"reduced":[348],"number":[350],"potential":[352],"\u201cdriver\u201d":[353],"alterations,":[354],"i.e.,":[355],"nonsynonymous":[356],"coding":[357,438],"expressed":[359],"tumor":[362],"but":[363],"present":[365,453],"exome.":[369],"For":[370],"example,":[371],"129":[374],"#536,":[382],"only":[383],"15":[384],"recovered":[386],"transcriptome.":[390],"Sequence":[391],"affected":[393],"histone":[400],"modification,":[401],"oxygen":[402],"metabolism,":[403],"steroid":[405],"responsiveness.":[406],"our":[408],"knowledge,":[409],"none":[410],"been":[417],"described.":[418],"One":[419],"gene":[423],"E2F":[426],"transcription":[427],"observed":[429],"two":[431],"cases.":[434],"addition,":[436],"2,428":[437],"exome,":[458],"possibly":[459],"indicating":[460],"rate":[463],"editing.":[466],"Additional":[467],"analysis":[469],"molecular":[471],"epidemiology":[472],"\u2014unrearranged":[481],"underway.":[484],"Disclosures:":[485],"No":[486],"relevant":[487],"conflicts":[488],"interest":[490],"declare.":[492]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2017-03-03T00:00:00"}